Sector consensus Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Delayed
NSE India S.E.
07:57:52 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,792.90 INR | +0.56% |
|
+8.07% | +51.86% |
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 08-12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 2,175.59 | +17.83% | 32 | ||||||
| 14,433.33 | +29.8% | 12 | ||||||
| 1,197.45 | +3.02% | 30 | ||||||
| 1,509.08 | +9.03% | 36 | ||||||
| 257.83 | -0.64% | 6 | ||||||
| 13,214.57 | +4.88% | 7 | ||||||
| 2,497.73 | +1.48% | 11 | ||||||
| - | 2,508.33 | +5% | 12 | |||||
| - | - | - | - | - | ||||
| 3,796.46 | +7.88% | 13 | ||||||
| 172.67 | +8.27% | 3 | ||||||
| 15.11 | +52.14% | 4 | ||||||
| - | - | - | - | - | ||||
| - | - | 133.12 | +1.78% | 2 | ||||
| - | 154.68 | +16.48% | 4 | |||||
| - | - | 14.6 | +8.79% | 1 | ||||
| Average | 3,005.75 | +11.84% | 12 | ||||||
| Weighted average by Cap. | 5,193.63 | +15.71% | 20 |
Select your edition
All financial news and data tailored to specific country editions
